Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung

Christian Grommes, David C. Preston, Zaid Al-Kadhimi, Amer Alshekhlee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Lambert-Eaton syndrome (LES) is an immune-mediated disorder of the presynaptic neuromuscular junction due to the blocking effect of the voltage-gated calcium channel (VGCC) antibodies. Small-cell lung cancer (SCLC) is the most common cause of LES. We report an unusual case of LES associated with large-cell neuroendocrine carcinoma (LCNEC) of the lung. In this case, clinical symptoms of LES predated the diagnosis of LCNEC by 6 years. After tumor resection, the patient experienced clinical and electrophysiological improvement. In addition, he had a decrease in VGCC antibody titer from 130 to 80 pmol/L. The onset of LES can be prolonged, and tumor surveillance should continue in these cases.

Original languageEnglish (US)
Pages (from-to)786-789
Number of pages4
JournalMuscle and Nerve
Volume37
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Lambert-Eaton Myasthenic Syndrome
Neuroendocrine Carcinoma
Large Cell Carcinoma
Lung
Calcium Channels
Antibodies
Neuromuscular Junction
Immune System Diseases
Small Cell Lung Carcinoma
Neoplasms

Keywords

  • Lambert-Eaton
  • Neuroendocrine carcinoma nerve conduction
  • Repetitive nerve stimulation

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung. / Grommes, Christian; Preston, David C.; Al-Kadhimi, Zaid; Alshekhlee, Amer.

In: Muscle and Nerve, Vol. 37, No. 6, 01.06.2008, p. 786-789.

Research output: Contribution to journalArticle

Grommes, Christian ; Preston, David C. ; Al-Kadhimi, Zaid ; Alshekhlee, Amer. / Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung. In: Muscle and Nerve. 2008 ; Vol. 37, No. 6. pp. 786-789.
@article{c8b1f6bb09314445b7185dd6cdb050a3,
title = "Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung",
abstract = "Lambert-Eaton syndrome (LES) is an immune-mediated disorder of the presynaptic neuromuscular junction due to the blocking effect of the voltage-gated calcium channel (VGCC) antibodies. Small-cell lung cancer (SCLC) is the most common cause of LES. We report an unusual case of LES associated with large-cell neuroendocrine carcinoma (LCNEC) of the lung. In this case, clinical symptoms of LES predated the diagnosis of LCNEC by 6 years. After tumor resection, the patient experienced clinical and electrophysiological improvement. In addition, he had a decrease in VGCC antibody titer from 130 to 80 pmol/L. The onset of LES can be prolonged, and tumor surveillance should continue in these cases.",
keywords = "Lambert-Eaton, Neuroendocrine carcinoma nerve conduction, Repetitive nerve stimulation",
author = "Christian Grommes and Preston, {David C.} and Zaid Al-Kadhimi and Amer Alshekhlee",
year = "2008",
month = "6",
day = "1",
doi = "10.1002/mus.21032",
language = "English (US)",
volume = "37",
pages = "786--789",
journal = "Muscle & nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung

AU - Grommes, Christian

AU - Preston, David C.

AU - Al-Kadhimi, Zaid

AU - Alshekhlee, Amer

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Lambert-Eaton syndrome (LES) is an immune-mediated disorder of the presynaptic neuromuscular junction due to the blocking effect of the voltage-gated calcium channel (VGCC) antibodies. Small-cell lung cancer (SCLC) is the most common cause of LES. We report an unusual case of LES associated with large-cell neuroendocrine carcinoma (LCNEC) of the lung. In this case, clinical symptoms of LES predated the diagnosis of LCNEC by 6 years. After tumor resection, the patient experienced clinical and electrophysiological improvement. In addition, he had a decrease in VGCC antibody titer from 130 to 80 pmol/L. The onset of LES can be prolonged, and tumor surveillance should continue in these cases.

AB - Lambert-Eaton syndrome (LES) is an immune-mediated disorder of the presynaptic neuromuscular junction due to the blocking effect of the voltage-gated calcium channel (VGCC) antibodies. Small-cell lung cancer (SCLC) is the most common cause of LES. We report an unusual case of LES associated with large-cell neuroendocrine carcinoma (LCNEC) of the lung. In this case, clinical symptoms of LES predated the diagnosis of LCNEC by 6 years. After tumor resection, the patient experienced clinical and electrophysiological improvement. In addition, he had a decrease in VGCC antibody titer from 130 to 80 pmol/L. The onset of LES can be prolonged, and tumor surveillance should continue in these cases.

KW - Lambert-Eaton

KW - Neuroendocrine carcinoma nerve conduction

KW - Repetitive nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=44949112261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949112261&partnerID=8YFLogxK

U2 - 10.1002/mus.21032

DO - 10.1002/mus.21032

M3 - Article

C2 - 18506722

AN - SCOPUS:44949112261

VL - 37

SP - 786

EP - 789

JO - Muscle & nerve

JF - Muscle & nerve

SN - 0148-639X

IS - 6

ER -